Royalty Report: Agriculture, Forestry and Fishing, Livestock – Collection: 121485

License Grant

In general, Norwegian Licensor shall supply Licensee with Products, and shall put its Technology related to pig breeding and reproduction at  Licensees disposal; Licensee shall Exploit Licensors Products and Technology in its crossbreeding program for the purpose of producing Derived Products to be sold in the Territory.

Hence Licensor grants to Licensee the non-exclusive distributorship for its Derived Products in the Territory.

License Property

Derived Products shall mean Genetic Materials directly or indirectly derived from the Products, to be Exploited by Licensee in the Territory.

Genetic Materials shall mean Breeding Pigs, their semen and/or their embryos.

Breeding Pig shall mean a male or female pig destined for the production of other pigs.

Technology shall mean Licensors know-how and methodology related to pig breeding and reproduction, including its updating, pat at Licensees disposal for the purpose of this Agreement.

Field of Use

This agreement pertains to the agriculture industry relating to animals.

License Grant

Licensee purchased physical assets, including livestock, heavy equipment and Licensor's rights under agreements with third parties, including one with an international developer and distributor of porcine genetic materials and technology.  Licensee is hereby granted a right of first refusal to purchase Licensor's residence and land.

License Property

Licensor is in the business of developing, producing, marketing, selling and distributing breeding pigs and their semen.

Field of Use

Licensee is primarily involved in the marketing of hog genetics and through the use of embryo transplants to create genetically superior, disease free, herds.

License Grant

The  Company has a research agreement with the University to investigate a natural, organic trace mineral supplement using the Company’s Promax animal feed supplement for pigs.

Field of Use

The Company’s Promax animal feed supplement, for pigs that could improve pig performance and reduce the occurrence of odor.

License Grant

In this license agreement for NFGA002, Licensor, a not-for-profit foundation, grants an exclusive sublicense to
– Access to Breeder Seed, whether produced by either party; and
– Produce all seed of the Licensed Variety in the Licensed Production Territory, wherein the right to produce Breeder Seed shall be non-exclusive between the parties; and
– Use, sell and commercially exploit the seed of the Licensed Variety in the Licensed Territory; and
– Make sublicenses under any and all Intellectual Property Rights.

License Property

The property includes switchgrass varieties NF/GA991, NF/GA992, NF/GA001 and NF/GA002.

This relationship provides us access to extensive breeding infrastructure and exclusive licenses to elite switchgrass varieties, breeding lines and advanced cultivars.

Field of Use

This agreement is for the crop production industry.

Licensee has the ability to assume production of and to commercialize energy crops, including, switchgrass crops and wishes to produce, use, sell and commercially exploit NF/GA002 seed.

License Grant

Licensor hereby grants Netherlands Licensee and its Affiliates a non-exclusive, worldwide, non-terminable license with the right to grant sublicenses, under the Licensor Patent Rights (other than the Licensor Antibody Patent Rights), for all uses in the Field, including, without limitation, to make, have made, use, sell, offer for sale, import and export Licensee Licensed Products in the Field. Such license shall not expire until the earlier of (i) the expiration of the last to expire Valid Claim of the Licensor Patent Rights other than the Licensor Antibody Patent Rights or (ii) termination of this Agreement of this Agreement.

License Property

Licensor Patent Rights shall mean (a) USSN 07/938,322 entitled 'Transgenic Animals Secreting Desired Proteins into Milk', including, without limitation, EP-973031124, and any foreign counterpart applications, together with any and all patents that have issued or in the case of applications heretofore filed, in the future issue therefrom or whose priority date is based thereon; and (b) all related divisionals,  continuations, national stage applications or patents filed under the Patent Cooperation Treaty of 1978, reissues or renewals, of the foregoing; and (c) the Licensor Antibody Patent Rights.

Licensor Antibody Patent Rights shall mean (a) U.S. Patent Nos. 5,827,690 and 5,849,992 both entitled 'Transgenic Production of Antibodies in Milk', and all U.S. patent applications and any foreign counterpart applications, and future issued patents including all patents that have issued or in the case of applications heretofore filed, in the future issue therefrom or whose priority date is based thereon; and all related divisionals, continuations, national stage applications or patents filed under the Patent Cooperation Treaty of 1978, reissues or renewals, of the foregoing pertaining to the production of antibodies in the milk of transgenic mammals.

Biopharmaceutical shall mean any medicinal drug, therapeutic, vaccine or any medically useful composition whose origin, synthesis, or manufacture involves the use of microorganisms, recombinant animals (including, without limitation, chimeric or transgenic animals), nuclear transfer, microinjection, or cell culture techniques.

HSA shall mean human serum albumin.

Field of Use

Field shall mean (a) the Cattle Field; (b) the Goat Field; (c) the production, use and/or sale of transgenic or chimeric mice, rabbits, pigs, and/or sheep (including their respective embryos, gametes and/or progeny) for the production of Biopharmaceuticals in the milk (including any fraction thereof) secreted from such transgenic or chimeric animals; and (d) the use in any transgenic or chimeric cattle, goats, mice, rabbits, pigs, and/or sheep of a nucleic acid construct useful in the production of a system that includes the use of a recombinant casein promoter sequence, which permits a female transgenic or chimeric animal to produce a desired Biopharmaceutical in the milk (or any fraction thereof) of such a transgenic or chimeric cattle, goats, mice, rabbits, pigs, and/or sheep
during lactation.

Goat Field shall mean the production, use and/or sale of transgenic or chimeric goats (including their respective embryos, gametes and/or progeny) for the production of Biopharmaceuticals in the milk (including any fraction thereof) secreted from such transgenic or chimeric goats.

Cattle Field shall mean the production, use and/or sale of transgenic or chimeric cattle (including their respective embryos, gametes and/or progeny) for the production of Biopharmaceuticals in the milk (including any fraction thereof) secreted from such transgenic or chimeric cattle, including, without limitation, the production of hSA.